|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| C12N 15/88 | (2006.01) | ||
| C12N 9/22 | (2006.01) | ||
| A61K 9/127 | (2006.01) | ||
| A61K 31/7088 | (2006.01) |
| (11) | Number of the document | 3688162 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18800355.2 |
| Date of filing the European patent application | 2018-09-28 | |
| (97) | Date of publication of the European application | 2020-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-06 |
| (46) | Date of publication of the claims translation | 2024-05-27 |
| (86) | Number | PCT/US2018/053559 |
| Date | 2018-09-28 |
| (87) | Number | WO 2019/067992 |
| Date | 2019-04-04 |
| (30) | Number | Date | Country code |
| 201762566240 P | 2017-09-29 | US |
| (72) |
WOOD, Kristy, M. , US
GARDNER, Noah, Paul , US
SHAH, Ruchi, Rudraprasad , US
SCULLY, Stephen, S. , US
MAJZOUB, Ramsey , US
|
| (73) |
Intellia Therapeutics, Inc. ,
40 Erie Street, Cambridge, MA 02139,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Preparatai |
| FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-09-03 | 8 | 185.00 EUR |
| 2026-09-28 |